SynbiCITE’s Post

💥 SynBioBeta 2024 is almost here, and we're counting down the days! Don't forget to visit Stemloop at booth 413 in the exhibit hall for a chance to learn about our cutting-edge biosensors and our vision for a smarter, more innovative world. 🌎   🔬Curious about how our cell-free biosensor platform can revolutionize your biomanufacturing processes? Or just want to talk about the future of synthetic biology? Either way, we're here to chat. Drop by our booth to discuss your projects and explore how we can work together to solve some of the world's toughest challenges. 🌎   We've got some special treats in store for our booth visitors—hint: you won't leave empty-handed. 😎 From stylish gear to fun collectibles, we've got just the thing to remember us by. 😉   🕒 Schedule a time to meet with us or just swing by. Whether you're a VP of R&D, a startup founder, an executive decision-maker, or just curious about the future of synthetic biology, we look forward to connecting with you at SynBioBeta 2024! 🌟   💬 Here's a question for you: Which sessions or talks at SynBioBeta 2024 are you most interested in attending? Share your picks in the comments! We’d love to hear what you're looking forward to, and it might just inspire others to check out the same sessions. Plus, your response could get you one of our exclusive giveaways! 🎁   #SynBioBeta2024 #SyntheticBiology #Innovation #Startup #Biosensors

[𝐌𝐚𝐲 𝗿𝗲𝗽𝗼𝗿𝘁] 𝗡𝗲𝘄 𝘀𝘁𝗮𝗿𝘁𝘂𝗽 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗮𝗻𝗱 𝘀𝘁𝗲𝗮𝗹𝘁𝗵 𝗮𝗰𝘁𝗶𝘃𝗶𝘁𝘆 𝗶𝗻 🇩🇪 𝗚𝗲𝗿𝗺𝗮𝗻𝘆, 🇨🇭 𝗦𝘄𝗶𝘁𝘇𝗲𝗿𝗹𝗮𝗻𝗱 & 🇦🇹 𝗔𝘂𝘀𝘁𝗿𝗶𝗮 In this report: • A pioneering biotech platform focused on decoding and manipulating RNA modifications for targeted cancer therapies 💊 • A platform providing artists with immediate cash offers in exchange for a percentage of their future music streaming revenues 🎵 • A digital B2B broker for timber procurement, connecting construction companies directly with sawmills for seamless transactions 🌲 • A geochemical verification system to authenticate the origin of mineral resources, ensuring supply chain compliance and traceability ⛏️ • An AI-driven tool making genomic data actionable to enhance patient care and accelerate drug discovery 🧬 • Technology aiming to automate and enhance administrative processes for public sector workers using machine learning 📑 • An AI-powered solution addressing energy management challenges with predictive analytics and smart grid integration ⚡ • An infrastructure solution supporting the burgeoning cannabis industry in Europe, focusing on sustainable cultivation practices 🌿 Read the full report: https://lnkd.in/dUKvVucv Until next time! #techstartups #startups #vc #preseed #angelinvestors #emergingtech #DACH #venturecapital

📈 Early stage biotechnology companies are faced with a unique and challenging existence. Automation can become their biggest asset in that fight. 🤖 🥊 Download the eBook to learn: 1️⃣ The value of automation for startup biotechs 2️⃣ The key considerations of bringing automation into labs 3️⃣ Fellow startup professionals' experience with automation To reach scale, find what fits - How automation helps early stage biotechs scale 🎉 🤖 📖 Get it here: https://bit.ly/3SlEJSu!

A little bit of Friday reading... At Opentrons, we are creating automation solutions that companies can utilize from Day 1. Read more in our ebook!

Launching groundbreaking research is no small feat, especially for an early-stage biotech. Knowing how overwhelming this process can be, we gathered everything you need to know about joining a biotech incubator, from discovery, application, selection, and making the most out of the experience. This comprehensive guide cuts through the confusion, laying out each step of the process and answering the most common questions. Share this eBook with your team to help you navigate the incubator journey with ease: https://hubs.li/Q02H9GxG0 #biotech #labops #labincubators #lifescience

🔋 Hello #batterytech community. As already mentioned in a previous post, I am currently working with the digital platform chemeurope.com / chemie.de on the #VirtualBatteryDay 2024, which will take place on November 13th. Find out more here: bit.ly/vbd2024-Visitors We want to give #scientists an easy way to share their #research and innovation in our #ScienceSession in a 10-20 minute pre-recorded presentation. Find out more and register here: bit.ly/vbd2024-Scientists Here are all the links to gather the information you need. Visitors & Free registration: bit.ly/vbd2024-Visitors  Startups & Free Pitch Session: bit.ly/vbd2024-Startups  Scientists & Free Science Session : bit.ly/vbd2024-Scientists  Advertising Opportunities: bit.ly/vbd2024-Adverising I hope you are interested in sharing your research with us and the community. If you are missing something that is relevant to you, please leave me your comment. I look forward to seeing you there. #batterytech #batteryindustry #batteryresearch

🔥 𝗨𝗻𝗹𝗼𝗰𝗸 𝘁𝗵𝗲 𝗸𝗲𝘆 𝘁𝗼 𝘄𝗶𝗻𝗻𝗶𝗻𝗴 𝗰𝘂𝘀𝘁𝗼𝗺𝗲𝗿𝘀! 🔥 Top tips from expert Dr. Rebekka Müller!💡 After the summer break is before the next event! We are excitedly looking forward to our next Check-in – it will be the very first event for the Batch #4 teams in Phase 1 after the Bootcamp. In order to properly kick off Phase 1 of the MAX!mize incubator for Max Planck start-ups, which is centred around the #validation and #exploration of the #startup idea for 6 months, there are many valuable #workshops on the agenda. To get things started here and now, we would like to introduce you to Dr. Rebekka Müller. Together with the teams, she will take a closer look at the topics of #CustomerDefinition & #ValueProposition. 🚀 As technology scout at Ascenion GmbH, Rebekka is working together with founders, inventors and scientists from research institutions and university hospitals, helping them advance their projects towards application. She combines deep industry and market experience from her previous marketing roles at Sanofi with profound scientific expertise, holding a PhD in molecular medicine. We interviewed Rebekka in advance and asked her the following question: 𝗜𝗻 𝘆𝗼𝘂𝗿 𝗼𝗽𝗶𝗻𝗶𝗼𝗻, 𝘄𝗵𝗮𝘁 𝗮𝗿𝗲 𝘁𝗵𝗲 𝘁𝗵𝗿𝗲𝗲 𝗺𝗼𝘀𝘁 𝗶𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁 𝗳𝗮𝗰𝘁𝗼𝗿𝘀 𝘁𝗵𝗮𝘁 𝗻𝗲𝗲𝗱 𝘁𝗼 𝗯𝗲 𝗰𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗲𝗱 𝘄𝗶𝘁𝗵 𝗿𝗲𝗴𝗮𝗿𝗱 𝘁𝗼 𝗰𝘂𝘀𝘁𝗼𝗺𝗲𝗿 𝗱𝗲𝗳𝗶𝗻𝗶𝘁𝗶𝗼𝗻 & 𝘃𝗮𝗹𝘂𝗲 𝗽𝗿𝗼𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻? ⬇️ You can find her answer in the slideshow. Would you have expected this?

At Opentrons, we are creating automation solutions that companies can utilize from Day 1. Read more in our ebook!

We are thrilled to share that Irene González Barahona González, our Key Account Manager, and Julio Martin Martín, ourSenior Strategic Liaison, were recently featured in an insightful interview with Technology Networks magazine. ❔ What are the key challenges you currently face? Irene González Barahona highlighted the challenges faced by startups like ours, particularly the scarcity of resources which requires multitasking and strategic choices about conference participation. "We would love to exhibit at all the conferences, but as a start-up, it's just not feasible," Julio Martin discussed the crucial role of customer feedback in shaping our solutions. "Understanding our users' problems is essential. We rely on insights from our target customers to enhance our technology applications, especially in the expansive field of cell biology," . Their thoughts underscore the importance of direct interactions at events and conferences, providing us with valuable feedback that helps us tailor our innovative solutions to meet specific needs. 🔗 Stay tuned for more updates and breakthroughs from A4cell as we continue to navigate the challenges and opportunities in cell biology. #A4cell #TechnologyWorks #CellBiology #Innovation #BusinessInsights #StartupChallenges #CustomerFeedback #IndustryEvents

Briefly Bio, a techbio startup, has secured $1.2 million in pre-seed funding to address the reproducibility crisis in preclinical research. The funding round, led by Compound VC with participation from NP Hard, Tiny VC, and angel investors, will support Briefly Bio's mission to improve scientific collaboration and accelerate discovery through consistent experiment documentation. The company's software utilizes AI to convert existing experiment descriptions into a consistent format, automatically filling gaps and spotting errors. This approach helps capture the value of every experiment, enabling scientists to learn from each other's work effectively. 'Scientific methods are a bit like software code, they are a set of instructions that define how an experiment should be run,' said Harry Rickerby, CEO and co-founder at Briefly Bio. 'Now, with LLMs, there's a way to make these methods consistent without imposing on a scientists' workflow.' Briefly Bio aims to create a shared language for experiments, facilitating collaboration among scientists, data scientists, and automation teams. By addressing the reproducibility crisis, the company aims to accelerate scientific discovery and generate reliable experimental results. #reproducibility #scientificdiscovery #labautomation